Description of Medical ServiceThe proposed service is testing of the ROS1 gene rearrangement by fluorescence in situ hybridisation (FISH) to determine eligibility to access entrectinib under the PBS.
This submission requests a minor amendment to MBS item 73344 be made allowing its use to determine eligibility to access crizotinib or entrectinib under the PBS.
Description of Medical ConditionNon-small cell lung cancer.
Reason for ApplicationAmendment to MBS item
Medical Service TypeInvestigative
Previous Application Number/sNot Applicable
Public Summary DocumentPublic Summary Document (PDF 436 KB)
Public Summary Document (Word 151 KB)